Mirati Therapeutics, Inc. Pre-Tax Profit Margin 2013-2023 | MRTX
Mirati Therapeutics, Inc. pre-tax profit margin from 2013 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-09-30 | $0.04B | $-0.73B | -1910.53% |
| 2023-06-30 | $0.03B | $-0.74B | -2729.63% |
| 2023-03-31 | $0.02B | $-0.74B | -4088.89% |
| 2022-12-31 | $0.01B | $-0.74B | -6158.33% |
| 2022-09-30 | $0.01B | $-0.74B | -6700.00% |
| 2022-06-30 | $0.08B | $-0.64B | -821.79% |
| 2021-09-30 | $0.07B | $-0.48B | -648.65% |
| 2020-12-31 | $0.01B | $-0.36B | -2753.85% |
| 2020-09-30 | $0.01B | $-0.33B | -2741.67% |
| 2020-03-31 | $0.00B | $-0.26B | -8633.33% |
| 2019-12-31 | $0.00B | $-0.21B | -5325.00% |
| 2019-09-30 | $0.01B | $-0.17B | -2816.67% |
| 2018-12-31 | $0.01B | $-0.10B | -825.00% |
